Urology Laser Market Size, Share, Growth, and Industry Analysis, By Type (Holmium Laser System,Diode Laser System,Thulium Laser System,Others), By Application (Benign Prostatic Hyperplasia (BPH),Urolithiasis,Non-Muscle-Invasive Bladder Cancer (NMIBC),Others), Regional Insights and Forecast to 2035

Urology Laser Market Overview

The global Urology Laser Market is forecast to expand from USD 1424.9 million in 2026 to USD 1520.52 million in 2027, and is expected to reach USD 2557.52 million by 2035, growing at a CAGR of 6.71% over the forecast period.

The Urology Laser Market has witnessed significant advancements in recent years due to technological innovation and growing demand for minimally invasive procedures. In 2024, over 1.2 million procedures using urology lasers were performed globally, highlighting the increasing adoption across hospitals and urology centers. Holmium laser systems dominate the market, accounting for approximately 42% of installed units worldwide. Thulium laser systems follow with 28%, primarily due to their efficiency in soft tissue ablation and reduced perioperative complications.

The market for urology lasers has shown strong growth in both hospital and clinic settings. Hospitals account for 63% of global demand, while outpatient clinics represent 37%, driven by growing patient preference for non-invasive procedures and reduced recovery times. Over 70% of procedures involve urolithiasis and benign prostatic hyperplasia (BPH), emphasizing the high clinical relevance of lasers in urology treatments.

The U.S. market remains a leading hub for urology laser adoption, accounting for roughly 38% of global installations. Over 450 hospitals and 1,200 outpatient centers in the country currently employ urology laser systems. Holmium lasers constitute 45% of all installed systems, while Thulium lasers account for 27%, and Diode lasers 22%. Procedures targeting BPH and urolithiasis dominate clinical usage, representing 72% of total applications in 2024.

The U.S. market has seen rapid expansion in outpatient settings, with nearly 320 centers performing more than 300 procedures annually using laser systems. Laser adoption has enhanced surgical precision, reducing hospital stay durations by an average of 1.8 days per patient. Furthermore, over 60% of advanced urology centers in the U.S. have integrated dual-wavelength Holmium-Thulium lasers to increase ablation speed by 35% and reduce intraoperative bleeding by 20%.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% of hospitals report rising demand for minimally invasive urology procedures, while 72% of patients prefer laser-assisted surgeries for faster recovery. Around 65% of healthcare facilities cite improved procedural precision as the main driver for adopting advanced urology laser systems.
• Major Market Restraint: 42% of medical facilities identify high equipment costs as a limiting factor. Around 38% of small clinics delay adoption due to maintenance expenses, and 35% of emerging-market hospitals struggle with financial constraints associated with upgrading existing urology laser systems.
• Emerging Trends: 55% of urology centers have integrated dual-wavelength Holmium-Thulium lasers. Approximately 47% of hospitals are adopting AI-assisted laser systems, while 52% of clinics report increased preference for outpatient laser surgeries using energy-efficient, compact diode-based urology laser devices.
• Regional Leadership: North America leads with 38% of global market share, followed by Europe at 32%. Asia-Pacific represents 20% and the Middle East & Africa account for 10%. Within North America, the United States alone contributes 85% of the regional market activity.
• Competitive Landscape: Top five companies dominate 64% of the global market. Lumenis holds 28% share, Boston Scientific Corporation 22%, Olympus 6%, Cook Medical 5%, and CR Bard 3%. Over 70% of hospitals prefer products from these leading urology laser manufacturers.
• Market Segmentation: Holmium lasers represent 42% of installations, Thulium lasers 28%, Diode lasers 20%, and others 10%. By application, 40% relate to BPH treatments, 32% to urolithiasis, 18% to NMIBC, and 10% to other urological procedures worldwide.
• Recent Development: 48% of newly installed systems in 2024 feature enhanced energy efficiency. Around 35% integrate AI-based control modules, 30% employ fiber-optic precision systems, and 25% of manufacturers developed compact outpatient-use laser units targeting small and medium healthcare facilities.

Urology Laser Market Latest Trends

The global urology laser market continues to expand, driven by innovation in energy efficiency and laser precision. In 2024, approximately 1.2 million laser-assisted procedures were performed globally, marking a 22% increase compared to 2022. The trend toward minimally invasive surgeries has encouraged adoption across hospitals, with North American centers installing 38% of total global units.

Hybrid Holmium-Thulium systems have gained popularity, with a reported 30% increase in clinical use in specialized urology centers. These systems have improved stone ablation efficiency by 35%, while bleeding and collateral tissue damage were reduced by 20%. Diode lasers, representing 20% of installations, continue to be favored in clinics performing outpatient procedures due to lower maintenance costs and reduced energy consumption.

Urology Laser Market Dynamics

DRIVER

"Rising demand for minimally invasive procedures."

The demand for minimally invasive urology procedures is driving market expansion. Hospitals report that 68% of patients prefer laser-assisted procedures for conditions such as BPH and urolithiasis due to faster recovery and reduced hospitalization. Clinical studies indicate that laser-assisted BPH surgeries reduce intraoperative blood loss by 18% compared to traditional methods. Additionally, outpatient centers performing laser procedures increased by 22% between 2022 and 2024, reflecting growing patient preference and procedural efficiency.

RESTRAINT

"High upfront costs of laser equipment."

High initial investment costs limit widespread adoption. Approximately 42% of hospitals report that the purchase of advanced urology laser systems, ranging from $80,000 to $250,000 per unit, is a major financial barrier. Maintenance costs, including fiber replacement and software updates, add an additional 12-15% annually. Smaller clinics with limited budgets struggle to justify these investments despite clinical benefits. These financial constraints slow adoption rates in emerging markets, where only 28% of hospitals currently utilize laser systems.

OPPORTUNITY

"Expansion of outpatient urology procedures."

The growing trend toward outpatient procedures offers significant growth opportunities. In 2024, outpatient centers performed over 370,000 laser-assisted surgeries in North America alone. Diode lasers, which constitute 22% of installations, are highly suitable for outpatient settings due to lower energy consumption and reduced operational costs. Expanding insurance coverage for minimally invasive procedures has encouraged clinics to invest in laser systems, increasing the potential customer base by 35% over two years.

CHALLENGE

"Training and skill requirements."

Effective utilization of laser systems requires specialized training. Approximately 58% of urologists in advanced hospitals have completed certified laser training programs. Lack of skilled personnel in emerging markets has resulted in underutilization of 42% of installed systems. Additionally, procedural complexities in combining multiple laser types, such as Holmium-Thulium hybrid systems, require extensive clinical expertise. Continuous training programs are necessary to maintain procedural safety, with hospitals investing an average of $25,000 annually per urologist for certification.

Urology Laser Market Segmentation

The Urology Laser Market is segmented by type—Holmium, Diode, Thulium, and Others—and by application, including Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer, and other urological conditions across hospitals and clinics globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Holmium Laser System: Holmium lasers account for 42% of global installations and are widely used for BPH and urolithiasis procedures. Over 500,000 procedures utilized Holmium systems in 2024. Hospitals report 35% faster operation times and 20% fewer complications. Around 60% of advanced urology centers use Holmium lasers due to their superior tissue ablation efficiency and versatility.

The Holmium Laser System segment is estimated at USD 532.4 million in 2025, holding 39.8% market share, and is expected to reach USD 956.1 million by 2034, expanding at a CAGR of 6.9%.

Top 5 Major Dominant Countries in the Holmium Laser System Segment

• United States: Market size USD 218.3 million by 2025 with 41.0% share and 7.0% CAGR driven by high adoption in BPH and urolithiasis procedures.
• Germany: Market size USD 68.4 million in 2025 with 12.8% share and 6.8% CAGR owing to wide hospital deployment and robust clinical infrastructure.
• China: Market size USD 56.9 million in 2025 with 10.7% share and 7.4% CAGR supported by rising demand for minimally invasive urology surgeries.
• Japan: Market size USD 45.2 million in 2025 with 8.5% share and 6.5% CAGR due to growing elderly population and advanced healthcare facilities.
• India: Market size USD 32.7 million in 2025 with 6.1% share and 7.1% CAGR driven by rapid hospital laser technology upgrades and cost-effective adoption.

Diode Laser System: Diode lasers hold 20% of total installations globally, primarily in outpatient settings. Approximately 320,000 procedures were performed with Diode lasers in 2024. Clinics adopting these systems experienced 22% shorter procedural durations and 15% fewer complications. These lasers are valued for compact design, 25% lower power consumption, and ease of use for soft tissue ablation.

The Diode Laser System segment is estimated at USD 267.1 million in 2025, accounting for 20.0% share, expanding steadily at a CAGR of 6.5%.

Top 5 Major Dominant Countries in the Diode Laser System Segment:

• United States: Market size USD 92.4 million (2025) with 34.6% share and 6.6% CAGR, driven by outpatient laser use and energy-efficient procedural systems.
• China: Market size USD 48.7 million (2025) capturing 18.2% share and 6.9% CAGR, attributed to strong clinical expansion and laser lithotripsy demand.
• Germany: Market size USD 38.5 million (2025) with 14.4% share and 6.4% CAGR, supported by advanced prostate and bladder treatment applications.
• Japan: Market size USD 31.6 million (2025) representing 11.8% share and 6.3% CAGR, bolstered by adoption in government-certified surgical centers.
• South Korea: Market size USD 23.8 million (2025) accounting for 8.9% share and 6.7% CAGR, propelled by advanced private hospital network expansion.

Thulium Laser System: Thulium lasers represent 28% of installed systems globally. Around 420,000 procedures were completed using Thulium lasers in 2024, with 17% lower post-operative complications and 20% faster recovery rates. Adoption increased 30% in specialized urology centers. Their precise cutting capability and minimal bleeding make them preferred for BPH and NMIBC treatments.

The Thulium Laser System segment is valued at USD 374.9 million in 2025, holding 28.1% share, projected to expand at a CAGR of 6.8%.

Top 5 Major Dominant Countries in the Thulium Laser System Segment:

• United States: Market size USD 134.6 million (2025) capturing 35.9% share and 6.9% CAGR, driven by NMIBC and soft tissue ablation procedures.
• Germany: Market size USD 54.2 million (2025) with 14.5% share and 6.7% CAGR, attributed to precision use in prostate and oncology applications.
• China: Market size USD 46.7 million (2025) accounting for 12.5% share and 7.0% CAGR, supported by widespread hospital modernization initiatives.
• Japan: Market size USD 37.9 million (2025) representing 10.1% share and 6.6% CAGR, driven by adoption in tertiary-care surgical environments.
• United Kingdom: Market size USD 29.8 million (2025) holding 7.9% share and 6.5% CAGR, reflecting strong healthcare infrastructure and hospital demand.

Others: Other laser systems, including hybrid and dual-wavelength types, contribute 10% of the global share. In 2024, approximately 120,000 procedures used these systems. About 60% of cases involved complex urolithiasis and NMIBC. Hospitals report 25% improved procedural precision and 18% shorter operation times using next-generation hybrid lasers for high-risk urology applications.

The “Others” segment, including hybrid and dual-wavelength systems, is projected at USD 161.9 million in 2025, representing 12.1% share, with a CAGR of 6.3%.

Top 5 Major Dominant Countries in the “Others” Laser System Segment:

• United States: Market size USD 57.8 million (2025) capturing 35.7% share and 6.5% CAGR, fueled by dual-laser systems in specialized treatment centers.
• China: Market size USD 33.2 million (2025) representing 20.5% share and 6.8% CAGR, driven by precision hybrid laser integration in large hospitals.
• Germany: Market size USD 25.9 million (2025) holding 16.0% share and 6.3% CAGR, utilized for complex urological reconstructive surgeries.
• India: Market size USD 22.1 million (2025) accounting for 13.6% share and 6.6% CAGR, supported by affordable access and hospital modernization.
• United Arab Emirates: Market size USD 15.6 million (2025) with 9.6% share and 6.2% CAGR, reflecting regional growth in private healthcare investment.

BY APPLICATION

Benign Prostatic Hyperplasia (BPH): BPH represents 40% of global laser-assisted urology procedures. Over 480,000 BPH surgeries utilized Holmium and Thulium lasers in 2024. Hospitals report a 35% reduction in operative time and 18% less blood loss. Laser systems improved urinary symptom relief by 32%, supporting strong clinical adoption for minimally invasive prostate tissue removal.

The BPH application segment is valued at USD 540.7 million in 2025, representing 40.5% market share, growing at a CAGR of 6.8%.

Top 5 Major Dominant Countries in the BPH Application Segment:

• United States: Market size USD 211.3 million (2025), 39.0% share, 6.9% CAGR, driven by rapid adoption of Holmium and Thulium laser systems across hospitals nationwide.
• Germany: Market size USD 69.5 million (2025), 12.8% share, 6.7% CAGR, supported by advanced medical facilities and rising demand for minimally invasive prostate surgeries.
• China: Market size USD 57.8 million (2025), 10.7% share, 7.1% CAGR, fueled by increasing BPH prevalence and expanding urology laser treatment adoption in hospitals.
• Japan: Market size USD 44.2 million (2025), 8.1% share, 6.6% CAGR, supported by high geriatric population and technological advancements in urology laser precision.
• India: Market size USD 31.7 million (2025), 5.9% share, 6.9% CAGR, driven by increasing patient awareness and improved access to affordable laser procedures.

Urolithiasis: Urolithiasis accounts for 32% of global laser applications. More than 380,000 procedures were conducted in 2024, primarily using Holmium lasers (42%) and Thulium lasers (30%). Clinical results show 30% higher stone clearance rates and 25% shorter procedure times. Laser lithotripsy adoption has grown 20% due to superior precision and reduced recurrence risk.

The Urolithiasis application segment stands at USD 427.3 million in 2025, capturing 32.0% market share, projected to grow at a CAGR of 6.7%.

Top 5 Major Dominant Countries in the Urolithiasis Application Segment:

• United States: Market size USD 155.6 million (2025), 36.4% share, 6.8% CAGR, driven by rising kidney stone prevalence and high adoption of laser lithotripsy technology.
• China: Market size USD 61.4 million (2025), 14.3% share, 7.0% CAGR, supported by expanding surgical facilities and increasing incidence of urinary calculi disorders.
• Germany: Market size USD 49.2 million (2025), 11.5% share, 6.6% CAGR, reflecting consistent demand for precision Holmium lasers in kidney stone treatment.
• India: Market size USD 36.9 million (2025), 8.6% share, 6.9% CAGR, fueled by cost-effective treatments and expanding availability of advanced surgical lasers.
• Japan: Market size USD 31.5 million (2025), 7.4% share, 6.5% CAGR, driven by clinical preference for energy-efficient Diode laser systems in stone removal.

Non-Muscle-Invasive Bladder Cancer (NMIBC): NMIBC represents 18% of total laser applications worldwide. Approximately 210,000 procedures were conducted in 2024, with Thulium lasers leading usage. Hospitals report 15% fewer cancer recurrence rates and 20% improved tissue precision. Laser ablation offers superior control and safety, with 22% faster healing times compared to conventional resection methods.

The NMIBC segment is valued at USD 240.4 million in 2025, representing 18.0% global share, expected to grow steadily at a CAGR of 6.8%.

Top 5 Major Dominant Countries in the NMIBC Application Segment:

• United States: Market size USD 88.3 million (2025), 36.7% share, 6.9% CAGR, supported by high Thulium laser adoption for advanced cancer ablation procedures.
• Germany: Market size USD 42.1 million (2025), 17.5% share, 6.6% CAGR, driven by technologically advanced oncology departments performing frequent NMIBC laser treatments.
• Japan: Market size USD 33.8 million (2025), 14.1% share, 6.5% CAGR, supported by growing healthcare focus on early-stage bladder cancer treatment precision.
• China: Market size USD 29.4 million (2025), 12.2% share, 7.0% CAGR, fueled by expansion of oncology laser centers and minimally invasive procedures.
• France: Market size USD 22.6 million (2025), 9.4% share, 6.4% CAGR, reflecting strong utilization of Thulium and hybrid lasers in oncology institutions.

Others: Other urology procedures represent 10% of laser use, covering urethral strictures and complex soft tissue ablations. About 120,000 surgeries were performed in 2024 using Holmium-Thulium hybrid systems. Hospitals reported 25% higher surgical precision and 20% reduced intraoperative bleeding, demonstrating strong adoption in advanced tertiary care centers globally.

The “Others” segment is projected at USD 127.1 million in 2025, holding 9.5% market share, and expanding at a CAGR of 6.5%.

Top 5 Major Dominant Countries in the “Others” Application Segment:

• United States: Market size USD 46.7 million (2025), 36.7% share, 6.6% CAGR, driven by use of hybrid lasers in complex urethral reconstructive surgeries.
• China: Market size USD 27.5 million (2025), 21.6% share, 6.8% CAGR, supported by growing demand for multi-functional laser systems in tertiary care hospitals.
• Germany: Market size USD 21.6 million (2025), 17.0% share, 6.4% CAGR, reflecting utilization of advanced urology lasers in high-precision clinical interventions.
• India: Market size USD 18.3 million (2025), 14.4% share, 6.7% CAGR, driven by medical training initiatives and increased imports of advanced surgical laser systems.
• United Arab Emirates: Market size USD 13.0 million (2025), 10.3% share, 6.5% CAGR, reflecting healthcare infrastructure expansion and focus on minimally invasive surgery.

Urology Laser Market Regional Outlook

The global Urology Laser Market shows strong regional presence, with North America leading adoption, Europe expanding installations, Asia-Pacific witnessing rapid growth, and the Middle East & Africa emerging with rising healthcare infrastructure investments.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

NORTH AMERICA

North America accounts for 38% of the global Urology Laser Market share. The United States contributes 85% of regional installations, with over 2,100 hospitals using advanced laser systems. Holmium lasers dominate at 45%, followed by Thulium at 27%. Outpatient procedures increased by 22% in 2024, supported by 320 specialized centers performing over 370,000 laser-assisted surgeries annually.

The North American Urology Laser Market is valued at USD 515.2 million in 2025, holding 38.6% share, growing at a CAGR of 6.8%.

North America – Major Dominant Countries in the Urology Laser Market:

• United States: Market size USD 428.9 million (2025), 83.2% share, 6.9% CAGR, driven by widespread hospital adoption of Holmium and Thulium laser systems for urology procedures.
• Canada: Market size USD 38.2 million (2025), 7.4% share, 6.6% CAGR, supported by advanced healthcare infrastructure and increasing demand for precision-based surgical laser technologies.
• Mexico: Market size USD 22.6 million (2025), 4.4% share, 6.5% CAGR, fueled by growing private-sector investments and expanding hospital-based urology departments.
• Panama: Market size USD 12.3 million (2025), 2.4% share, 6.4% CAGR, driven by improving medical facilities and laser technology adoption in emerging healthcare networks.
• Costa Rica: Market size USD 13.2 million (2025), 2.6% share, 6.5% CAGR, supported by medical tourism and new investments in urology treatment centers nationwide.

EUROPE

Europe represents 32% of the global Urology Laser Market. Over 1,700 hospitals use laser systems, with 40% adopting Holmium and 30% Thulium technologies. The region performed approximately 320,000 urology laser procedures in 2024. Germany, the UK, and France collectively contribute 60% of installations. Outpatient usage increased by 18%, driven by expanded adoption of dual-wavelength and energy-efficient laser platforms.

The European Urology Laser Market stands at USD 427.3 million in 2025, representing 32.0% share, and projected to grow at a CAGR of 6.7%.

Europe – Major Dominant Countries in the Urology Laser Market:

• Germany: Market size USD 136.8 million (2025), 32.0% share, 6.8% CAGR, driven by early Holmium laser adoption and strong procedural volumes across large hospitals.
• United Kingdom: Market size USD 86.3 million (2025), 20.2% share, 6.5% CAGR, supported by healthcare modernization and preference for minimally invasive urology surgeries.
• France: Market size USD 74.2 million (2025), 17.4% share, 6.4% CAGR, driven by expansion of advanced surgical technologies in both public and private hospitals.
• Italy: Market size USD 64.8 million (2025), 15.2% share, 6.6% CAGR, reflecting steady growth in Diode and Thulium laser system installations.
• Spain: Market size USD 53.1 million (2025), 12.4% share, 6.7% CAGR, fueled by new hospital investments and increased outpatient adoption of laser systems.

ASIA-PACIFIC

Asia-Pacific accounts for 20% of the Urology Laser Market. More than 1,000 hospitals have installed laser systems, with Holmium lasers comprising 38% and Thulium 30%. Annual procedural volume surpassed 220,000 surgeries in 2024. Japan, China, and India collectively represent 75% of installations, showing a 25% year-over-year increase fueled by rising healthcare investments and outpatient expansion.

The Asia-Pacific Urology Laser Market is valued at USD 267.1 million in 2025, accounting for 20.0% share, expanding at a CAGR of 6.9%.

Asia-Pacific – Major Dominant Countries in the Urology Laser Market:

• China: Market size USD 101.4 million (2025), 38.0% share, 7.0% CAGR, driven by large-scale hospital expansion and strong growth in urolithiasis laser procedures.
• Japan: Market size USD 72.4 million (2025), 27.1% share, 6.6% CAGR, supported by advanced healthcare technology and high adoption of Thulium laser systems.
• India: Market size USD 54.9 million (2025), 20.5% share, 7.1% CAGR, fueled by increasing BPH and kidney stone cases in rapidly developing healthcare infrastructure.
• South Korea: Market size USD 22.8 million (2025), 8.5% share, 6.8% CAGR, reflecting growing private hospital installations and precision urology treatment centers.
• Australia: Market size USD 15.6 million (2025), 5.9% share, 6.5% CAGR, supported by rising imports of hybrid and dual-wavelength laser systems for surgical use.

MIDDLE EAST & AFRICA

The Middle East & Africa hold 10% of global market share. Over 450 hospitals utilize laser systems, with Holmium lasers representing 35% and Thulium 28%. Approximately 120,000 procedures were performed in 2024. Saudi Arabia and the UAE account for 60% of installations, reflecting growing infrastructure development and a 20% increase in minimally invasive urology procedures.

The Middle East & Africa Urology Laser Market is projected at USD 107.6 million in 2025, holding 8.0% share, expanding at a CAGR of 6.9%.

Middle East and Africa – Major Dominant Countries in the Urology Laser Market:

• Saudi Arabia: Market size USD 34.5 million (2025), 32.1% share, 6.9% CAGR, supported by new hospital infrastructure and increasing demand for Thulium laser procedures.
• United Arab Emirates: Market size USD 28.1 million (2025), 26.1% share, 6.8% CAGR, driven by rapid private sector expansion and introduction of high-precision surgical lasers.
• South Africa: Market size USD 17.3 million (2025), 16.1% share, 6.7% CAGR, reflecting increased investment in advanced urology departments across tertiary hospitals.
• Qatar: Market size USD 14.7 million (2025), 13.6% share, 6.6% CAGR, driven by growing focus on healthcare digitization and surgical technology upgrades.
• Egypt: Market size USD 13.0 million (2025), 12.1% share, 6.5% CAGR, fueled by government initiatives to modernize hospitals and enhance surgical laser access.

List of Top Urology Laser Companies

• Allengers Medical Systems Limited
• Olympus Corporation
• Surgical Lasers Inc
• Lumenis
• OmniGuide Holdings Inc.
• CR BARD (BD)
• Boston Scientific Corporation
• Cook medical

Top Two companies with the highest market share:

• Lumenis: Holds 28% of global installations with over 1,400 units deployed in 2024.
• Boston Scientific Corporation: Accounts for 22% of global installations, with more than 1,100 systems operational in hospitals worldwide.

Investment Analysis and Opportunities

The urology laser market presents robust investment potential due to increasing procedural volumes and technological innovation. In 2024, over 1.2 million laser-assisted urology procedures were performed globally, highlighting a growing clinical need. Hospitals are investing in Holmium and Thulium systems, which represent 42% and 28% of installed units, respectively. Outpatient centers are expanding capacity, increasing the installed base of Diode lasers by 22% over two years.

Investors can capitalize on hybrid Holmium-Thulium lasers, which have shown a 30% adoption growth in specialized centers. Maintenance contracts and after-sales services offer additional revenue streams, as 60% of installed systems require annual servicing. Insurance coverage expansion for minimally invasive procedures is expected to boost demand by 35% in emerging markets. Partnerships with local distributors and training institutes further enhance market penetration, with 58% of urologists completing laser certification programs, ensuring widespread adoption.

New Product Development

Innovations in urology lasers focus on precision, energy efficiency, and fiber-optic delivery improvements. In 2024, over 1,000 new systems were launched, with dual-wavelength Holmium-Thulium lasers gaining 30% adoption in advanced centers. Fiber optics now deliver energy with 25% higher precision, reducing collateral tissue damage by 18%. Diode lasers have been upgraded for outpatient use, with 22% lower energy consumption and a compact design suitable for clinics.

Emerging laser systems now incorporate AI-assisted monitoring, enabling real-time adjustment of laser intensity during procedures. This innovation improves stone ablation efficiency by 35% and reduces intraoperative bleeding by 20%. Hospitals are increasingly investing in these systems, with 48% of 2024 installations featuring upgraded software for enhanced procedural control. These developments reflect a strong focus on procedural efficiency, patient safety, and adoption of minimally invasive surgery in both hospital and outpatient settings.

Five Recent Developments

• Lumenis introduced dual-wavelength Holmium-Thulium laser systems in 2024, adopted by 180 centers globally, improving stone ablation by 35%.
• Boston Scientific launched an AI-enabled laser system in 2023, increasing procedural precision by 25%.
• Olympus Corporation expanded outpatient laser installations in Europe by 18% in 2024, performing over 60,000 procedures.
• Surgical Lasers Inc. developed fiber-optic upgrades in 2023, improving energy delivery efficiency by 22%.
• OmniGuide Holdings, Inc. introduced soft tissue ablation systems in 2024, reducing intraoperative bleeding by 20% in NMIBC procedures.

Report Coverage of Urology Laser Market

The report provides comprehensive insights into the urology laser market, covering technology adoption, regional penetration, and application trends. In 2024, over 5,000 hospitals and 2,500 outpatient centers globally installed laser systems. Holmium lasers dominate with 42% market share, followed by Thulium at 28%, and Diode at 20%. Procedures for BPH and urolithiasis accounted for 72% of global surgeries. Regional analysis highlights North America with 38% market share, Europe 32%, Asia-Pacific 20%, and Middle East & Africa 10%.

The report also provides a detailed competitive landscape, highlighting that Lumenis and Boston Scientific Corporation together hold 50% of total installations. Emerging trends, including dual-wavelength lasers, AI-assisted systems, and outpatient adoption, are examined. Coverage extends to segmentation by type and application, market dynamics, technological advancements, recent developments, and investment opportunities. The scope includes the impact of laser efficiency improvements, fiber delivery enhancements, procedural accuracy, and clinical adoption rates across hospital and outpatient settings.

Urology Laser Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1424.9 Million in 2026
Market Size Value By	USD 2557.52 Million by 2035
Growth Rate	CAGR of 6.71% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Holmium Laser System Diode Laser System Thulium Laser System Others By Application : Benign Prostatic Hyperplasia (BPH) Urolithiasis Non-Muscle-Invasive Bladder Cancer (NMIBC) Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample